L-Citrulline for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

L-Citrulline for Health & Longevity

Created on 08/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

An amino acid from watermelon that raises arginine and widens arteries. Best evidence: better artery widening and a flatter pressure surge under cold and heavy effort; resting pressure drops modestly, though pooled analyses disagree. Gains cluster in raised pressure, past middle age, diabetes or excess weight. Well tolerated; stomach upset eases with split doses. (Full Review)

Protocol

Standard vascular dose
6 g daily
Plain L-Citrulline; the threshold at which pooled diastolic benefit appears. 10 g daily is reserved for non-responders at 6 g.
Best time of day
Split morning and evening
Suits the vascular target, since the effect tracks continuous arginine availability; twice-daily 3 g raised trough arginine better than once-daily dosing.
Pre-exercise dose
6-8 g citrulline malate
40-60 minutes before resistance training, the timing and dose used across the pooled repetition-performance trials.
Time to effect
Resting blood pressure & artery dilation
4-7 weeks
Continuous dosing is required before reassessment is meaningful.
Acute vascular and performance effects
Within 60 minutes
After a single dose.
Non-response decision point
8 weeks
The point at which 10 g daily is considered for non-responders at 6 g.

Benefits

Contraindications
  • Inherited urea-cycle disorders, including argininosuccinate lyase deficiency (unless citrulline is given under specialist supervision)
  • Decompensated cirrhosis or hepatic encephalopathy (Child-Pugh Class C)
  • Chronic kidney disease stage 4 or worse (eGFR below 30 mL/min/1.73 m²)
  • Symptomatic hypotension or resting systolic pressure persistently below 100 mmHg
  • Recent myocardial infarction (within 90 days) or unstable angina requiring frequent nitrate use
  • Pregnancy and lactation
    •
Key Interactions
  • Antihypertensive drugs (amlodipine, lisinopril, losartan, hydrochlorothiazide): additive blood pressure reduction
  • Nitrates and nitric oxide donors (nitroglycerin, isosorbide mononitrate): potentially severe hypotension
  • Phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil): hypotension and headache may be amplified
  • Over-the-counter analgesics (ibuprofen, naproxen, aspirin): blunt vasodilation and raise blood pressure
  • Over-the-counter decongestants (pseudoephedrine, phenylephrine): opposing vasoconstriction can mask benefit
  • Blood-pressure-lowering supplements (beetroot or dietary nitrate, arginine, garlic extract, hibiscus, magnesium, taurine): additive hypotension
  • Anticoagulants and antiplatelet agents (warfarin, apixaban, clopidogrel): theoretical additive bleeding tendency
  • Other interventions (sauna, heat exposure and alcohol): lightheadedness on standing

Risk & Side Effects

  • Medium: Gastrointestinal discomfort
    •
  • Low: Absent safety data in pregnancy and lactation
    •
  • Speculative: Additive hypotension with blood-pressure-lowering agents; herpes simplex reactivation; ammonia accumulation in urea-cycle or advanced liver disease; minor laboratory shifts at high intakes

Monitoring

Marker Target Why
Home systolic blood pressure 110-125 mmHg Primary efficacy endpoint; the benefit is largest when baseline is elevated
Home diastolic blood pressure 65-80 mmHg Diastolic response separates 6 g/day and higher from lower doses
Fasting glucose 4.4-5.2 mmol/L (80-94 mg/dL) Detects the glucose lowering seen in type 2 diabetes and flags metabolic drift
HbA1c 4.8-5.3% Confirms whether any fasting glucose change is durable rather than a single-morning artefact
eGFR Above 90 mL/min/1.73 m² The kidney performs the conversion to arginine and clears the compound
BUN 3.6-6.4 mmol/L (10-18 mg/dL) Confirms the added nitrogen load is being disposed of normally
ALT Below 25 U/L in men, below 20 U/L in women Screens liver function before and during a nitrogen-donating supplement
Flow-mediated dilation Above 7% The endpoint that moved most consistently in the meta-analysis of older adults
Plasma arginine-to-ADMA ratio No established target; track change from the individual's own baseline Indicates whether nitric oxide capacity is actually improving

Cadence: Seven days of home blood pressure at baseline, repeated at week 4, week 8, then every six months; metabolic panel at baseline, rechecked at three months and annually thereafter. For anyone on antihypertensive drugs or nitrates, days one to three after starting carry the most information.

Qualitative Assessment

  • Lightheadedness on standing, particularly in the first fortnight and after sauna, hot baths or alcohol
  • Stomach discomfort, heartburn or loose stools, and whether these resolve when the dose is split
  • Repetitions completed at a fixed load in the final sets of a resistance session
  • Perceived exertion during a familiar training session, and soreness the following day
  • Walking distance or pace on a habitual route, for those over 55 pairing the supplement with training
  • Erectile quality, where that is the reason for use
  • Cold tolerance, since the clearest trial signal is a blunted pressure surge during cold exposure
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.